FOLD logo

Amicus Therapeutics, Inc. (FOLD) Return On Equity

Annual ROE:

-31.68%+75.36%(+70.40%)
December 31, 2024

Summary

  • As of today, FOLD annual return on equity is -31.68%, with the most recent change of +75.36% (+70.40%) on December 31, 2024.
  • During the last 3 years, FOLD annual ROE has risen by +52.69% (+62.45%).
  • FOLD annual ROE is now -124.69% below its all-time high of 128.30%, reached on December 31, 2003.

Performance

FOLD ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDprofitability metrics

Quarterly ROE:

-21.09%-3.39%(-19.15%)
June 30, 2025

Summary

  • As of today, FOLD quarterly return on equity is -21.09%, with the most recent change of -3.39% (-19.15%) on June 30, 2025.
  • Over the past year, FOLD quarterly ROE has increased by +68.36% (+76.42%).

Performance

FOLD Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

FOLD ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+70.4%+76.4%
3Y3 Years+62.5%+80.3%
5Y5 Years+63.6%+65.6%

FOLD ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+71.2%-19.1%+85.4%
5Y5-Yearat high+71.2%-19.1%+85.4%
All-TimeAll-Time-124.7%+85.3%>-9999.0%+87.1%

FOLD ROE History

DateAnnualQuarterly
Jun 2025
-
-21.09%(-19.2%)
Mar 2025
-
-17.70%(+49.8%)
Dec 2024
-31.68%(+70.4%)
-35.23%(+50.5%)
Sep 2024
-
-71.17%(+20.4%)
Jun 2024
-
-89.45%(+22.4%)
Mar 2024
-
-115.21%(+4.1%)
Dec 2023
-107.04%(+2.6%)
-120.19%(+16.5%)
Sep 2023
-
-143.95%(+0.1%)
Jun 2023
-
-144.06%(-8.7%)
Mar 2023
-
-132.58%(-9.3%)
Dec 2022
-109.93%(-30.3%)
-121.31%(-12.9%)
Sep 2022
-
-107.43%(-0.2%)
Jun 2022
-
-107.25%(-10.2%)
Mar 2022
-
-97.32%(-11.5%)
Dec 2021
-84.37%(-16.2%)
-87.26%(-5.9%)
Sep 2021
-
-82.38%(+6.5%)
Jun 2021
-
-88.07%(-12.6%)
Mar 2021
-
-78.21%(-4.3%)
Dec 2020
-72.59%(+16.6%)
-74.96%(-7.1%)
Sep 2020
-
-70.00%(-14.1%)
Jun 2020
-
-61.34%(+6.4%)
Mar 2020
-
-65.56%(+11.0%)
Dec 2019
-86.99%(+13.3%)
-73.65%(-0.6%)
Sep 2019
-
-73.23%(+21.6%)
Jun 2019
-
-93.37%(-1.9%)
Mar 2019
-
-91.61%(-15.0%)
Dec 2018
-100.32%(-25.9%)
-79.67%(-5.7%)
Sep 2018
-
-75.35%(-8.8%)
Jun 2018
-
-69.25%(+7.6%)
Mar 2018
-
-74.91%(+10.3%)
Dec 2017
-79.66%(-41.0%)
-83.51%(-2.9%)
Sep 2017
-
-81.19%(-25.3%)
Jun 2017
-
-64.79%(-1.4%)
Mar 2017
-
-63.91%(-8.0%)
Dec 2016
-56.51%(-0.5%)
-59.17%(-9.7%)
Sep 2016
-
-53.92%(-4.6%)
Jun 2016
-
-51.56%(-0.1%)
Mar 2016
-
-51.50%(+0.1%)
Dec 2015
-56.22%
-51.54%(+8.8%)
Sep 2015
-
-56.51%(+20.1%)
DateAnnualQuarterly
Jun 2015
-
-70.74%(+38.3%)
Mar 2015
-
-114.69%(+7.3%)
Dec 2014
-82.09%(+20.9%)
-123.70%(+24.5%)
Sep 2014
-
-163.86%(-2.3%)
Jun 2014
-
-160.12%(-8.1%)
Mar 2014
-
-148.09%(-16.4%)
Dec 2013
-103.74%(-5.1%)
-127.23%(-17.6%)
Sep 2013
-
-108.17%(-14.2%)
Jun 2013
-
-94.72%(-26.0%)
Mar 2013
-
-75.17%(-1.5%)
Dec 2012
-98.74%(-5.1%)
-74.03%(+7.3%)
Sep 2012
-
-79.83%(-3.4%)
Jun 2012
-
-77.19%(+14.5%)
Mar 2012
-
-90.27%(+6.9%)
Dec 2011
-93.97%(-17.0%)
-96.98%(+4.7%)
Sep 2011
-
-101.72%(-0.0%)
Jun 2011
-
-101.70%(-13.3%)
Mar 2011
-
-89.74%(-6.4%)
Dec 2010
-80.34%(-774.2%)
-84.31%(-629.3%)
Sep 2010
-
-11.56%(-37.9%)
Jun 2010
-
-8.38%(+32.7%)
Mar 2010
-
-12.45%(-9.5%)
Dec 2009
-9.19%(+79.6%)
-11.37%(+87.3%)
Sep 2009
-
-89.42%(-30.2%)
Jun 2009
-
-68.66%(-25.1%)
Mar 2009
-
-54.89%(-24.0%)
Dec 2008
-45.15%(-28.2%)
-44.25%(-16.6%)
Sep 2008
-
-37.94%(-2.3%)
Jun 2008
-
-37.10%(+5.5%)
Mar 2008
-
-39.26%(-1.5%)
Dec 2007
-35.23%(+58.6%)
-38.69%(-41.0%)
Sep 2007
-
-27.43%(-50.9%)
Jun 2007
-
-18.18%(-80.4%)
Mar 2007
-
-10.08%(>-9900.0%)
Dec 2006
-85.03%(+39.1%)
0.00%(0.0%)
Sep 2006
-
0.00%(+100.0%)
Jun 2006
-
-20.27%(+50.0%)
Mar 2006
-
-40.53%(+33.3%)
Dec 2005
-139.71%(+35.1%)
-60.80%
Dec 2004
-215.20%(-267.7%)
-
Dec 2003
128.30%
-

FAQ

  • What is Amicus Therapeutics, Inc. annual return on equity?
  • What is the all-time high annual ROE for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. annual ROE year-on-year change?
  • What is Amicus Therapeutics, Inc. quarterly return on equity?
  • What is the all-time high quarterly ROE for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. quarterly ROE year-on-year change?

What is Amicus Therapeutics, Inc. annual return on equity?

The current annual ROE of FOLD is -31.68%

What is the all-time high annual ROE for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high annual return on equity is 128.30%

What is Amicus Therapeutics, Inc. annual ROE year-on-year change?

Over the past year, FOLD annual return on equity has changed by +75.36% (+70.40%)

What is Amicus Therapeutics, Inc. quarterly return on equity?

The current quarterly ROE of FOLD is -21.09%

What is the all-time high quarterly ROE for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high quarterly return on equity is 0.00%

What is Amicus Therapeutics, Inc. quarterly ROE year-on-year change?

Over the past year, FOLD quarterly return on equity has changed by +68.36% (+76.42%)
On this page